One of my relatives in the US, who has MS, was given a cannabis sweet to try to see if it was any good. They had never taken cannabis before and not knowing what to expect, they had a bite of the sweet and nothing. However, it made them go to sleep, they then woke, up a bit dopey, with the “munchies” (a well known side effect of cannabis that stimulates the desire to eat). What did they find first? Yep a bag of sweets/candies, which we all rapidly eaten…Ooops…now essentially paralysed and unable to move because of way too much cannabis, the children find my relative on the floor and thinking its a serious relapse or something serious, it’s off to A & E (ER in American) leading to an eventual embarrassing talk with the physician. That ended their cannabis experimentation.
This episode does show that cannabis overdose does not tend to kill you..which is a good thing but it does lead to the question why are so called “medical cannabis producers” making very high content THC sweets (candies), that largely serve the function of getting people taking them very high. Packaging as candy/sweets make you wonder who are the target buyers and the responsibility of some cannabis producers out to make a buck.
In the US they are letting a genie out of a bottle with legalisation for recreational use along with medical marijuana, so the experiment begins.
Having met a number of PotDocs who are prescribing marijuana who go off to “Medicate”……..I think the sooner that the pharmaceutical side can dissociate the medical and recreational sides the better. I suspect it is because of this type of image that no big pharmaceutical company has ventured into the cannabinoid world.
Most of the big pharma have had cannabinoid programmes. I wonder if Sanofi (the makers of Lemtraa) who took the plunge with cannabinoid drugs and was burned (cannabinoid receptor antagonist used to suppress appetite, the opposite of the munchies, which unfortunately appeared to make some people so depressed they killed themselves), will develop any of their cannabinoid-related drugs (just check out there patent portfolio) for MS?
COI: We are developing alternative symptomatic medicines